132 related articles for article (PubMed ID: 35737153)
1. Search for New Target Genes of MicroRNA for Differential Diagnosis of Benign and Malignant Neoplasms of the Thyroid Gland by In Silico Methods.
Kononchuk VV; Kopeikina EV; Kalinina TS; Saik OV; Alekseenok EY; Kolyagina MK; Matashova VA; Shevchenko SP; Gulyaeva LF; Kushlinskii NE
Bull Exp Biol Med; 2022 Jun; 173(2):246-251. PubMed ID: 35737153
[TBL] [Abstract][Full Text] [Related]
2. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
Takano T; Yamada H
Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
[TBL] [Abstract][Full Text] [Related]
3. DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma.
Zhang H; Zhang Z; Liu X; Duan H; Xiang T; He Q; Su Z; Wu H; Liang Z
J Clin Endocrinol Metab; 2021 Mar; 106(4):1011-1021. PubMed ID: 33394038
[TBL] [Abstract][Full Text] [Related]
4. APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions.
Castelblanco E; Zafon C; Maravall J; Gallel P; Martinez M; Capel I; Bella MR; Halperin I; Temprana J; Iglesias C; Puig-Domingo M; Robledo M; Matias-Guiu X; Mauricio D
Thyroid; 2017 Jan; 27(1):59-66. PubMed ID: 27796194
[TBL] [Abstract][Full Text] [Related]
5. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
[TBL] [Abstract][Full Text] [Related]
7. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human follicular thyroid adenomas from carcinomas by gene expression profiling.
Zhao J; Leonard C; Gemsenjäger E; Heitz PU; Moch H; Odermatt B
Oncol Rep; 2008 Feb; 19(2):329-37. PubMed ID: 18202778
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers for discrimination of benign and malignant follicular thyroid tumors.
Fryknäs M; Wickenberg-Bolin U; Göransson H; Gustafsson MG; Foukakis T; Lee JJ; Landegren U; Höög A; Larsson C; Grimelius L; Wallin G; Pettersson U; Isaksson A
Tumour Biol; 2006; 27(4):211-20. PubMed ID: 16675914
[TBL] [Abstract][Full Text] [Related]
11. [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
Cerutti JM
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):832-42. PubMed ID: 17891248
[TBL] [Abstract][Full Text] [Related]
12. How to define follicular thyroid carcinoma?
Schmid KW; Farid NR
Virchows Arch; 2006 Apr; 448(4):385-93. PubMed ID: 16506015
[TBL] [Abstract][Full Text] [Related]
13. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
[TBL] [Abstract][Full Text] [Related]
16. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
Pyo JS; Kim DH; Yang J
Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression array identifies novel diagnostic markers for conventional and oncocytic follicular thyroid carcinomas.
Dettmer M; Vogetseder A; Durso MB; Moch H; Komminoth P; Perren A; Nikiforov YE; Nikiforova MN
J Clin Endocrinol Metab; 2013 Jan; 98(1):E1-7. PubMed ID: 23150679
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
[TBL] [Abstract][Full Text] [Related]
20. Combined quantitation of HMGA2 mRNA, microRNAs, and mitochondrial-DNA content enables the identification and typing of thyroid tumors in fine-needle aspiration smears.
Titov SE; Ivanov MK; Demenkov PS; Katanyan GA; Kozorezova ES; Malek AV; Veryaskina YA; Zhimulev IF
BMC Cancer; 2019 Oct; 19(1):1010. PubMed ID: 31660895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]